נוראקסון ביולוג'יק בע"מ

ExoTherapy: A proprietary platform for developing exosome-Based therapies. Exosomes are nanosized extracellular vesicles with a natural ability to reach inflamed or damaged tissue. By loading exosomes with therapeutic compounds, nanodrugs are created having natural regenerative properties and therapeutic impact.

Physicians, People with spinal cord injuries and other Central Nervous System (CNS) traumatic injuries.

Lior Shaltiel - CEO

Eran Ovadya - CFO